| 英文名稱 | PD184352(CI-1040) |
|---|---|
| 中文名稱 | PD184352(CI-1040) |
| CAS號(hào) | 212631-79-3 |
| 分子式 | C17H14ClF2 IN2O2 |
| 分子量 | 478.66 |
| 外觀 | White to off-white powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
| 英文名稱 | PD184352(CI-1040) |
|---|---|
| 中文名稱 | PD184352(CI-1040) |
| CAS號(hào) | 212631-79-3 |
| 分子式 | C17H14ClF2 IN2O2 |
| 分子量 | 478.66 |
| 外觀 | White to off-white powder |
| 儲(chǔ)存條件 | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
PD184352 (PD-184352; CI-1040), an analog of benzhydroxamate, is an orally bioactive, specific, allosteric/non-ATP competitive MEK1/2 inhibitor with potential anticancer activity. In cell-based assays, it inhibits MEK1/2 with IC50 values of 17 nM and exhibits a 100-fold preference for MEK1/2 over MEK5. In mouse xenograft models, it exhibits strong in vitro anti-proliferative activity and significant in vivo antitumor efficacy.